This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Sep 24;114(13):2567-8.

doi: 10.1182/blood-2009-07-230904.

NK antibody therapy: KIR-ative intent

Nina Shah¹, Elizabeth J Shpall

Affiliations

PMID: 19779042
DOI: 10.1182/blood-2009-07-230904

Free article

Comment

NK antibody therapy: KIR-ative intent

Nina Shah et al. Blood. 2009.

Free article

. 2009 Sep 24;114(13):2567-8.

doi: 10.1182/blood-2009-07-230904.

Authors

Nina Shah¹, Elizabeth J Shpall

Affiliation

¹ M D ANDERSON CANCER CENTER, USA.

PMID: 19779042
DOI: 10.1182/blood-2009-07-230904

No abstract available

PubMed Disclaimer

Comment on

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM Jr, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, Wagtmann N. Romagné F, et al. Blood. 2009 Sep 24;114(13):2667-77. doi: 10.1182/blood-2009-02-206532. Epub 2009 Jun 24. Blood. 2009. PMID: 19553639 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database